3.43
Oncology Institute Inc stock is traded at $3.43, with a volume of 1.19M.
It is up +1.48% in the last 24 hours and up +20.77% over the past month.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
See More
Previous Close:
$3.38
Open:
$3.38
24h Volume:
1.19M
Relative Volume:
0.62
Market Cap:
$339.02M
Revenue:
$502.73M
Net Income/Loss:
$-50.26M
P/E Ratio:
-6.0891
EPS:
-0.5633
Net Cash Flow:
$-27.79M
1W Performance:
+10.65%
1M Performance:
+20.77%
6M Performance:
-14.46%
1Y Performance:
+80.53%
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TOI
Oncology Institute Inc
|
3.43 | 334.08M | 502.73M | -50.26M | -27.79M | -0.5633 |
|
HCA
Hca Healthcare Inc
|
488.58 | 111.48B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
193.56 | 17.10B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.84 | 12.68B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
197.92 | 11.59B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
180.15 | 11.10B | 17.36B | 1.51B | 849.25M | 23.15 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
[144] Oncology Institute, Inc. SEC Filing - Stock Titan
Market Overview: Is The Oncology Institute Inc Equity Warrant a potential multi bagger2026 EndofYear Setup & Verified Swing Trading Watchlists - baoquankhu1.vn
Aug Selloffs: Will The Oncology Institute Inc outperform during market rallies - baoquankhu1.vn
Chernett Jorey buys oncology institute (TOI) shares worth $62000 By Investing.com - Investing.com South Africa
Chernett Jorey buys oncology institute (TOI) shares worth $62000 - Investing.com
Oncology Institute reports $1.8M Medicare savings in latest period By Investing.com - Investing.com Canada
Oncology Institute (NASDAQ: TOI) 10% owner buys 20,000 shares in open market - Stock Titan
The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement - Yahoo Finance
Setup Watch: Will The Oncology Institute Inc be affected by tariffsTrade Signal Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Investment Recap: Is The Oncology Institute Inc showing insider buyingPortfolio Risk Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
MACD Signal: Is The Oncology Institute Inc Equity Warrants ROE strong enough2026 Earnings Surprises & Low Risk Investment Opportunities - baoquankhu1.vn
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - 富途牛牛
The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference - Bitget
EPS Watch: Is The Oncology Institute Inc Equity Warrant a stock for growth or value investors - baoquankhu1.vn
Cancer care company CEO, CFO join virtual Needham event April 15 - Stock Titan
Can The Oncology Institute Inc ride the EV wavePortfolio Update Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Earnings Beat: What are the risks of holding The Oncology Institute IncMarket Activity Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
Market Overview: Can The Oncology Institute Inc ride the EV wavePortfolio Update Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Is The Oncology Institute Inc impacted by rising ratesWeekly Profit Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
The Oncology Institute Names Minh Merchant Chief Legal Officer - Bitget
Aug Opening: What is The Oncology Institute Inc Equity Warrants market position2026 PreEarnings & Consistent Growth Stock Picks - baoquankhu1.vn
The Oncology Institute names Minh Merchant as chief legal officer By Investing.com - Investing.com Australia
The Oncology Institute names Minh Merchant as chief legal officer - Investing.com
The Oncology Institute, Inc. Announces Appointment of Minh Merchant as Chief Legal Officer - marketscreener.com
Oncology Institute taps veteran healthcare lawyer as it scales - Stock Titan
The Oncology Institute, Inc. (TOI) stock price, news, quote and history - Yahoo Finance UK
TOI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
RSU grant boosts Oncology Institute (NASDAQ: TOI) admin chief stake - Stock Titan
Oncology Institute (TOI) CFO gets 202,914 RSUs, sells 20,320 shares for taxes - Stock Titan
Oncology Institute (TOI) CEO awarded 670K RSUs as issuer sells shares for taxes - Stock Titan
Oncology Institute (TOI) CMO gets 66,446-share RSU grant and tax sale - Stock Titan
Market Catalysts: What analysts say about The Oncology Institute Inc stock2026 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
One Oncology Institute Insider Raised Their Stake In The Previous Year - Yahoo Finance
Retail Trends: What is The Oncology Institute Inc Equity Warrants revenue forecastQuarterly Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Oncology institute (TOI) ten percent owner Chernett buys $81,189 in stock By Investing.com - Investing.com South Africa
Oncology institute (TOI) ten percent owner Chernett buys $81,189 in stock - Investing.com India
Insider at Oncology Institute (TOI) buys 27,429 company shares - Stock Titan
The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue - MSN
Winners Losers: Should I hold or sell The Oncology Institute Inc Equity Warrant now2026 Closing Moves & Community Trade Idea Sharing - baoquankhu1.vn
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
TOI - Finviz
Chernett Jorey buys Oncology Institute (TOI) shares worth $157,500 By Investing.com - Investing.com South Africa
Chernett Jorey buys Oncology Institute (TOI) shares worth $157,500 - Investing.com
Major TOI holder Jorey Chernett adds 50,000 Oncology Institute shares - stocktitan.net
Aug Patterns: What are the risks of holding The Oncology Institute Inc Equity Warrant2026 Market Overview & Safe Capital Growth Stock Tips - baoquankhu1.vn
Published on: 2026-03-26 19:40:28 - baoquankhu1.vn
Chernett Jorey buys oncology institute (TOI) shares worth $388,750 By Investing.com - Investing.com Australia
Insider Buying: Jorey Chernett Acquires 125,000 Shares of The On - GuruFocus
Jorey Chernett Acquires 125,000 Shares of Oncology Institute (NASDAQ:TOI) Stock - MarketBeat
Chernett Jorey buys oncology institute (TOI) shares worth $388,750 - Investing.com
Oncology Institute Insider Bought Shares Worth $388,750, According to a Recent SEC Filing - marketscreener.com
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oncology Institute Inc Stock (TOI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chernett Jorey | 10% Owner |
Apr 09 '26 |
Buy |
3.10 |
20,000 |
62,000 |
10,499,358 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
2.96 |
27,429 |
81,190 |
10,479,358 |
| Chernett Jorey | 10% Owner |
Mar 26 '26 |
Buy |
3.15 |
50,000 |
157,500 |
10,451,929 |
| Chernett Jorey | 10% Owner |
Mar 24 '26 |
Buy |
3.11 |
125,000 |
388,750 |
10,401,929 |
| Chernett Jorey | 10% Owner |
Mar 20 '26 |
Buy |
3.35 |
25,000 |
83,750 |
10,276,929 |
| Chernett Jorey | 10% Owner |
Mar 13 '26 |
Buy |
2.92 |
263,000 |
767,960 |
10,115,944 |
| Chernett Jorey | 10% Owner |
Mar 17 '26 |
Buy |
3.42 |
75,000 |
256,500 |
10,251,929 |
| Chernett Jorey | 10% Owner |
Mar 16 '26 |
Buy |
3.29 |
60,985 |
200,641 |
10,176,929 |
| Carter Robert Ross | Chief Financial Officer |
Jan 02 '26 |
Sale |
3.56 |
247 |
879 |
235,122 |
| Hively Brad | Director |
Dec 15 '25 |
Sale |
3.77 |
13,333 |
50,291 |
683,721 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):